- Tytuł:
- Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199).
- Autorzy:
- Źródło:
- Gynecologic Oncology. Aug2013, Vol. 130 Issue 2, p269-274. 6p.
Czasopismo naukowe